Risk of COVID-19 in newborns depending on the infection course in the mother
https://doi.org/10.22625/2072-6732-2022-14-1-105-110
Abstract
The incidence of the new coronavirus infection (COVID-19) remains a global problem worldwide. However, the effect of COVID-19 on the course of pregnancy and the possibility of intrauterine infection are insufficiently investigated. Recent studies suggest the possibility of a transplacental transmission of infection caused by SARS-CoV-2.
Goal: To analyze SARS-Cov-2 RNA detection cases in newborns and to study possible factors influencing the infection of newborns from mothers with COVID-19.
Materials and methods. From March to August 2020, there were 64 births to women with a confirmed diagnosis of COVID-19 at the Botkin’s Infection Disease Hospital. In 15 newborns, the diagnosis of COVID-19 was laboratory confirmed. In this study, the histories of 14 newborns and their mothers were analyzed retrospectively. The diagnosis of COVID-19 was based on the detection of SARS-Cov-2 RNA in a nasopharyngeal swab or in fecal samples.
Results. Analysis of the histories of mothers showed that 4 (28.6%) patients had an asymptomatic disease. Three (21.4%) women had a severe course of COVID-19, 7 (50%) patients had a course of moderate severity. Fetal hypoxia was more common in women with severe or moderate course of COVID-19. In 6 (42.7%) newborns, a positive nasopharyngeal swab was obtained within 48 hours after birth. None of the women whose children were RNA-positive in the first two days had a severe form of the disease, and two patients had an asymptomatic disease.
Conclusion.
1. The frequency of detection of SARS-CoV-2 RNA in newborns from mothers with COVID-19 (under mother-child separation) was 21.9%.
2. Infection of a newborn with SARS-CoV-2 is possible both with a severe course of the disease in the mother and with an asymptomatic course.
3. A caesarean section does not exclude the possibility of a newborn infection with SARS-CoV-2.
4. In newborns, in most cases, an asymptomatic course of COVID-19 is observed.
About the Authors
M. A. BelopolskayaRussian Federation
Saint-Petersburg
A. I. Gareeva
Russian Federation
Saint-Petersburg
V. Yu. Avrutin
Germany
Stuttgart
A. V. Dmitriev
Russian Federation
Saint-Petersburg
D. A. Gusev
Russian Federation
Saint-Petersburg
References
1. Characteristics of swine flu clinical course in the dead pregnant women and in cases which nearly led to lethal outcome / Belokrinickaja T. E., Tarbaeva D. A., Trubicyna A. Ju. [et al.] // Lechashhij vrach – 2013. – № 3. – P. 31 (in Russian)
2. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections / Schwartz D. A., Graham A. L. // Viruses, 2020;12(02):194.
3. What are the risks of COVID-19 infection in pregnant women? / Qiao J. // Lancet, 2020;395(10226):760–762.
4. COVID-19, SARS-CoV-2 and pregnancy: does the past predict the present? / Schwartz D.A. // Contagion Live, February 28, 2020. https://www. contagionlive.com/news/covid19-sarscov2-and-pregnancy-does-the-pastpredict-the-present. Accessed March 1, 2020
5. A systematic scoping review of COVID-19 during pregnancy and childbirth / Elshafeey F., Magdi R., Hindi N., Elshebiny M., Farrag N., Mahdy S. [et al.] // Int. J. Gynaecol. Obstet. 2020; Apr 24. https://dx.doi.org/10.1002/ijgo.13182.
6. World Health Organization. Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection, 2020. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-managementpatients.htm
7. A case report of neonatal COVID 19 infection in China / Wang S., Guo L., Chen L., Weiyong LiuW., Yong CaoY., Jingyi ZhangJ., Ling Feng L. [et al.] // Clin. Infect. Dis. 2020; March 12: ciaa225. https://dx.doi.org/10.1093/cid/ciaa225
8. Severe COVID-19 during pregnancy and possible vertical transmission / Alzamora M.C., Paredes T., Caceres D., [et al.] // American journal of perinatology, 2020. – Т 37. – № 8. – С. 861.
9. A review of newborn outcomes during the COVID-19 pandemic / Kyle M.H., Glassman M. E., Khan A., [et al.] // Seminars in Perinatology.: WB Saunders, 2020. – С. 151-286.
10. Transplacental transmission of SARS-CoV-2 infection / Vivanti A.J., Vauloup-Fellous C., Prevot S. [et al.] // Nat Commun 11, 3572 (2020). https://doi.org/10.1038/s41467-020-17436-6
11. SARS-CoV-2: is it the newest spark in the TORCH? / K.M. Muldoon, K.B. Fowler, M.H. Pesch, M.R. Schleiss [ et al.] // J Clin Virol, 127 (2020), Article 104372, 10.1016/j.jcv.2020.104372
12. Kuznecov P.A., Kozlov P.V. Fetal hypoxia and neonatal asphyxia // Lechebnoe delo. 2017. №4. URL: https://cyberleninka.ru/article/n/gipoksiya-ploda-i-asfiksiya-novorozhdennogo (in Russian).
13. Buonocore, G. Neonatology. A Practical Approach to Neonatal Diseases / G. Buonocore, R. Bracci, M. Weindling. – Milan: Springer-Verlag Italia, 2012. – 1348 p
14. Е.Y. Leonova, О.Y. Sinyakin. Peculiarities of hemostatic system in newborns // Ohrana materinstva i detstva. – 2016. – № 2. – P. 76-81 (in Russian).
15. Wiedmeier, S. E. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system / S.E. Wiedmeier [et al.] // J. Perinatol. – 2009. – Vol. 29. – P. 130–136
16. Ishiguro, A. Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels / A. Ishiguro [et al.] // Br J Haematol. – 1999. – Vol. 106. – P. 884–884.
17. Bezhenar’ V. F. et al. Controversial issues in obstetric management of women with novel coronavirus disease COVID-19 during pregnancy and childbirth // Akusherstvo i ginekologija. – 2020. – V. 5. – P. 13-21. https://dx.doi.org/10.18565/aig.2020.5.13-21 (in Russian)
Review
For citations:
Belopolskaya M.A., Gareeva A.I., Avrutin V.Yu., Dmitriev A.V., Gusev D.A. Risk of COVID-19 in newborns depending on the infection course in the mother. Journal Infectology. 2022;14(1):105-110. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-1-105-110